125 related articles for article (PubMed ID: 36208272)
1. [Clinical Observation of Neutropenia Patients with Hematonosis Treated with Polymyxin B Sulfate].
Wu SQ; Zhan R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1596-1600. PubMed ID: 36208272
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection].
Zhou M; Kang HZ; Gu CY; Liu YJ; Wang Y; Miao M; Fu JH; Tang XW; Qiu HY; Fu CC; Jin ZM; Li CX; Chen SN; Sun AN; Wu DP; Han Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):484-489. PubMed ID: 37550204
[No Abstract] [Full Text] [Related]
3. Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study.
Ma L; Shen J; Jiang H; Qian S; Zhang J; Lan J; Zhou H; Lang W; Mei C; Zhou X; Zhu L; Xu G; Ye L; Hu C; Ren Y; Yang X; Jin J; Ye X; Tong H
J Infect; 2023 Apr; 86(4):406-409. PubMed ID: 36702310
[No Abstract] [Full Text] [Related]
4. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections.
Xia GL; Jiang RL
BMC Infect Dis; 2021 Oct; 21(1):1034. PubMed ID: 34607561
[TBL] [Abstract][Full Text] [Related]
6. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of sepsis with extensively drug resistant Gram-negative bacteria in intensive care unit treated with polymyxin B-based combination therapy].
Zhao S; Yan L; Wang C; Peng M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):150-154. PubMed ID: 32274997
[TBL] [Abstract][Full Text] [Related]
8. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
9. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
10. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
13. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
14. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria].
Zhou L; Li C; Weng Q; Wu J; Luo H; Xue Z; Xiao Y; Chen C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):416-420. PubMed ID: 34053483
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.
Mattos KPH; Gouvêa IR; Quintanilha JCF; Cursino MA; Vasconcelos PENS; Moriel P
J Clin Pharm Ther; 2019 Jun; 44(3):415-419. PubMed ID: 30666679
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin B-induced rhabdomyolysis: A case report.
Ni M; Meng X; Wang L; Zhao Y; Yu M; Shi S
Medicine (Baltimore); 2020 Oct; 99(43):e22924. PubMed ID: 33120846
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-Resistant Gram-Negative Bacteria-Related Healthcare-Associated Ventriculitis and Meningitis: Antimicrobial Resistance of the Pathogens, Treatment, and Outcome.
Ye Y; Kong Y; Ma J; Shi G
Microbiol Spectr; 2022 Jun; 10(3):e0025322. PubMed ID: 35467409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]